<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04720898</url>
  </required_header>
  <id_info>
    <org_study_id>2020-372b</org_study_id>
    <nct_id>NCT04720898</nct_id>
  </id_info>
  <brief_title>LUNA-EMG to Enhance Motor Functions in Multiple Sclerosis</brief_title>
  <acronym>LUNA-MS</acronym>
  <official_title>LUNA-EMG to Enhance Lower Limb Motor Functions in Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jean-François Kaux, MD PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Frank Houlmont</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate the effects of training performed with the&#xD;
      LUNA-EMG system to enhance motor functions of the lower limb in multiple sclerosis. This is a&#xD;
      randomized open-label trial. Patients will be randomized into the intervention group&#xD;
      (LUNA-EMG, 30-45 minutes once a week for 12 weeks) or in the control group (standard care).&#xD;
&#xD;
      The effect of the training will be measured based on the muscular strength, walking tests,&#xD;
      proprioception and a quality of life questionnaire.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle strength in mV</measure>
    <time_frame>12 weeks</time_frame>
    <description>Muscular strength is measured with a dynamometer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Timed 25-Foot Walk, seconds</measure>
    <time_frame>12 weeks</time_frame>
    <description>The patient is directed to one end of a clearly marked 25-foot course and is instructed to walk 25 feet as quickly as possible, but safely. The faster the better.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Up and Go, seconds</measure>
    <time_frame>12 weeks</time_frame>
    <description>The person must get up from the seated position and walk three meters away from the chair and then retrace their steps (turn 180 degrees) and sit down again. The faster the better.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proprioception</measure>
    <time_frame>12 weeks</time_frame>
    <description>Patients proprioception will be measured with the LUNA system. It calculates the distance in degree (°) between the target arm position and the arm position that the patient try to reproduce. Lower degree represent a more accurate positioning of the arm by the patient.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>LUNA-EMG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will receive 30 minutes of training with the LUNA-EMG once a week for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will receive its rehabilitation care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LUNA-EMG</intervention_name>
    <description>The LUNA-EMG (Samcom) system is a robot that allows the evaluation of muscular strength through the recording of muscle activity (electromyography - EMG) in order to provide precise objective data on the patient's muscle function. In addition to the diagnostic aspect (evaluation of muscle strength, range of motion and proprioception), the LUNA-EMG robot provides optimized range of motion's movements and a visual feedback on the patient's performance. In addition, it may enhance neuroplasticity due to the increased number of movements repetitions which could influence motor learning.</description>
    <arm_group_label>LUNA-EMG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  EDSS less or equal to 6.5&#xD;
&#xD;
          -  Between 18 and 70 years old&#xD;
&#xD;
          -  Having signed the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute pain syndrome&#xD;
&#xD;
          -  Severe cognitive deficits&#xD;
&#xD;
          -  Risk of fracture or unconsolidated fracture&#xD;
&#xD;
          -  Rigid joints (spasticity, severe osteoarthritis and arthritis) or unstable joints&#xD;
&#xD;
          -  Severe ataxia and apraxia&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Pacemakers and similar implants&#xD;
&#xD;
          -  Insufficient skin conditions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aurore Thibaut, PhD</last_name>
    <phone>+324843612</phone>
    <email>athibaut@uliege.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Frank Houlmont, MSc</last_name>
    <email>fhoulmont@chuliege.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CNRF</name>
      <address>
        <city>Tinlot</city>
        <state>Liege</state>
        <zip>4557</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurore Thibaut, PhD</last_name>
      <email>athibaut@uliege.be</email>
    </contact>
    <investigator>
      <last_name>Frank Houlmont</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>August 4, 2021</last_update_submitted>
  <last_update_submitted_qc>August 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Aurore Thibaut</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

